Back to Search Start Over

Intrathecal neurolysis for the management of refractory pain in a patient with terminal oncological disease: case report.

Authors :
Rangel Jaimes GW
Ortega Agón KA
Cediel Carrillo XJ
Source :
Pain management [Pain Manag] 2022 Jul; Vol. 12 (5), pp. 569-577. Date of Electronic Publication: 2022 Mar 17.
Publication Year :
2022

Abstract

We report on the successful treatment of refractory cancer pain by intrathecal neurolysis using 96% absolute alcohol. A female patient with colorectal adenocarcinoma with metastases to the sacral bones, the patient had severe pain refractory to pharmacological and interventional treatment. Intrathecal neurolytic block at the L5-S1 intervertebral space was performed, she reported a significant improvement in her pain and decreased opioid use. The patient did not show deterioration of neurological functions after the procedure or associated complications, and outpatient treatment continued with a home medicine program. She remained comfortable until her death 6 weeks later. Considering that this is an accessible and cost-effective procedure, it could be a helpful alternative for the management of patients with refractory pain in the terminal stage.

Details

Language :
English
ISSN :
1758-1877
Volume :
12
Issue :
5
Database :
MEDLINE
Journal :
Pain management
Publication Type :
Academic Journal
Accession number :
35297268
Full Text :
https://doi.org/10.2217/pmt-2021-0097